Stay updated on Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.

Latest updates to the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedExpanded the Locations section to include sites across Arizona, California, Connecticut, Florida, Illinois, Maryland, Minnesota, Missouri, Nevada, New Mexico, New York, Ohio, Oklahoma, Oregon, Tennessee, Texas, and Virginia, and noted Revision: v3.3.3.SummaryDifference1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe Publications section now states entries are auto-filled from PubMed and may not relate to the study, and the revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoval of the site-wide notice about government funding and NIH operating status is reflected on the page, with no impact on study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check93 days agoChange DetectedCore content updated with a government-operational notice and a version bump from v3.1.0 to v3.2.0; no other significant content changes detected.SummaryDifference3%

- Check100 days agoChange DetectedReplace the older JCO reference with the updated 2025 JCO citation (v3.0.2 -> v3.1.0) for the Avutometinib study; core content updated to include the latest publication details and version. No other page sections affected.SummaryDifference0.9%

- Check114 days agoChange DetectedRevision: v3.0.2 added; previous v3.0.1 removed, and the 'Back to Top' element was deleted.SummaryDifference0.2%

Stay in the know with updates to Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.